Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jorge Quiroga

Showing results (61-70 of 71) with videos related to

Pageof 8
Sort By:
Plos One|January 24, 2013
Zolmitriptan: a novel portal hypotensive agent which synergizes with propranolol in lowering portal pressureMercedes Reboredo, Haisul C Y Chang, Roberto Barbero, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|June 21, 2013
Trial of complete weaning from immunosuppression for liver transplant recipients: factors predictive of toleranceRocío García de la Garza, Pablo Sarobe, Juana Merino, et al.
Frontiers in Neurology|June 20, 2022
Dysautonomia in COVID-19 Patients: A Narrative Review on Clinical Course, Diagnostic and Therapeutic StrategiesFrancisco Carmona-Torre, Ane Mínguez-Olaondo, Alba López-Bravo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 16, 2004
Phase I trial of intratumoral injection of an adenovirus encoding interleukin-12 for advanced digestive tumorsBruno Sangro, Guillermo Mazzolini, Juan Ruiz, et al.
International Journal of Medical Sciences|January 22, 2019
Ultrasound/Elastography techniques, lipidomic and blood markers compared to Magnetic Resonance Imaging in non-alcoholic fatty liver disease adultsIrene Cantero, Mariana Elorz, Itziar Abete, et al.
Nutrients|October 27, 2019
The Metabolic and Hepatic Impact of Two Personalized Dietary Strategies in Subjects with Obesity and Nonalcoholic Fatty Liver Disease: The Fatty Liver in Obesity (FLiO) Randomized Controlled TrialBertha Araceli Marin-Alejandre, Itziar Abete, Irene Cantero, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 16, 2004
Intratumoral injection of dendritic cells engineered to secrete interleukin-12 by recombinant adenovirus in patients with metastatic gastrointestinal carcinomasGuillermo Mazzolini, Carlos Alfaro, Bruno Sangro, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 7, 2021
Effects of two personalized dietary strategies during a 2-year intervention in subjects with nonalcoholic fatty liver disease: A randomized trialBertha A Marin-Alejandre, Irene Cantero, Nuria Perez-Diaz-Del-Campo, et al.
Nutrients|February 6, 2019
Association between Sleep Disturbances and Liver Status in Obese Subjects with Nonalcoholic Fatty Liver Disease: A Comparison with Healthy ControlsBertha Araceli Marin-Alejandre, Itziar Abete, Irene Cantero, et al.
Biofactors (Oxford, England)|May 12, 2023
Mapping early serum proteome signatures of liver regeneration in living donor liver transplant casesLorena Carmona-Rodríguez, Aaron S Gajadhar, Irene Blázquez-García, et al.
Pageof 8

Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
Plos One|January 24, 2013
Zolmitriptan: a novel portal hypotensive agent which synergizes with propranolol in lowering portal pressureMercedes Reboredo, Haisul C Y Chang, Roberto Barbero, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|June 21, 2013
Trial of complete weaning from immunosuppression for liver transplant recipients: factors predictive of toleranceRocío García de la Garza, Pablo Sarobe, Juana Merino, et al.
Frontiers in Neurology|June 20, 2022
Dysautonomia in COVID-19 Patients: A Narrative Review on Clinical Course, Diagnostic and Therapeutic StrategiesFrancisco Carmona-Torre, Ane Mínguez-Olaondo, Alba López-Bravo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 16, 2004
Phase I trial of intratumoral injection of an adenovirus encoding interleukin-12 for advanced digestive tumorsBruno Sangro, Guillermo Mazzolini, Juan Ruiz, et al.
International Journal of Medical Sciences|January 22, 2019
Ultrasound/Elastography techniques, lipidomic and blood markers compared to Magnetic Resonance Imaging in non-alcoholic fatty liver disease adultsIrene Cantero, Mariana Elorz, Itziar Abete, et al.
Nutrients|October 27, 2019
The Metabolic and Hepatic Impact of Two Personalized Dietary Strategies in Subjects with Obesity and Nonalcoholic Fatty Liver Disease: The Fatty Liver in Obesity (FLiO) Randomized Controlled TrialBertha Araceli Marin-Alejandre, Itziar Abete, Irene Cantero, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 16, 2004
Intratumoral injection of dendritic cells engineered to secrete interleukin-12 by recombinant adenovirus in patients with metastatic gastrointestinal carcinomasGuillermo Mazzolini, Carlos Alfaro, Bruno Sangro, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 7, 2021
Effects of two personalized dietary strategies during a 2-year intervention in subjects with nonalcoholic fatty liver disease: A randomized trialBertha A Marin-Alejandre, Irene Cantero, Nuria Perez-Diaz-Del-Campo, et al.
Nutrients|February 6, 2019
Association between Sleep Disturbances and Liver Status in Obese Subjects with Nonalcoholic Fatty Liver Disease: A Comparison with Healthy ControlsBertha Araceli Marin-Alejandre, Itziar Abete, Irene Cantero, et al.
Biofactors (Oxford, England)|May 12, 2023
Mapping early serum proteome signatures of liver regeneration in living donor liver transplant casesLorena Carmona-Rodríguez, Aaron S Gajadhar, Irene Blázquez-García, et al.
Pageof 8